Hot Pursuit     04-Jul-24
Zydus Lifesciences Ltd spurts 2.26%, rises for third straight session
Zydus Lifesciences Ltd is quoting at Rs 1119.95, up 2.26% on the day as on 12:49 IST on the NSE. The stock is up 91.44% in last one year as compared to a 25.55% gain in NIFTY and a 46.49% gain in the Nifty Pharma index.

Zydus Lifesciences Ltd rose for a third straight session today. The stock is quoting at Rs 1119.95, up 2.26% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.28% on the day, quoting at 24354.6. The Sensex is at 80227.97, up 0.3%. Zydus Lifesciences Ltd has added around 6.8% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has added around 4.63% in last one month and is currently quoting at 19915.3, up 1.3% on the day. The volume in the stock stood at 13.33 lakh shares today, compared to the daily average of 15.07 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 1125.9, up 2.2% on the day. Zydus Lifesciences Ltd is up 91.44% in last one year as compared to a 25.55% gain in NIFTY and a 46.49% gain in the Nifty Pharma index.

The PE of the stock is 31.94 based on TTM earnings ending March 24.

Previous News
  Zydus Lifesciences consolidated net profit rises 26.76% in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   14:29 )
  Zydus Lifesciences Ltd drops for fifth straight session
 ( Hot Pursuit - 27-Jun-24   13:35 )
  Zydus receives USFDA approval for Methylene Blue Injection
 ( Corporate News - 06-Dec-23   14:28 )
  Zydus and Dr Reddy's ink licensing agreement to co-market Pertuzumab in India
 ( Corporate News - 28-Jun-24   19:04 )
  Zydus announces dissolution of its WoS - Zydus Noveltech Inc.
 ( Corporate News - 18-Dec-23   15:10 )
  Zydus partners with Lupin to market Saroglitazar Mg in India
 ( Corporate News - 03-Nov-23   14:46 )
  Zydus Lifesciences gets USFDA nod for ZITUVIO
 ( Hot Pursuit - 23-Oct-23   09:09 )
  Zydus Life gets USFDA nod for Sugammadex injection
 ( Hot Pursuit - 06-Oct-23   14:57 )
  Zydus SEZ-2 units at Ahmedabad clears USFDA inspection
 ( Corporate News - 08-Jul-23   10:46 )
  Zydus receives USFDA approval for Diclofenac Sodium and Misoprostol Delayed Release Tablets
 ( Corporate News - 13-Jun-23   15:11 )
  Board of Zydus Lifesciences approves buyback of Rs 600 cr
 ( Corporate News - 09-Feb-24   17:50 )
Other Stories
  PEL board OKs ad hoc appointments post Rupen Patel's passing
  06-Jul-24   16:41
  Info Edge Q1 FY25 billings climb 11% YoY
  06-Jul-24   15:50
  IndusInd Bank advances climb 16% YoY in Q1 FY25
  06-Jul-24   15:18
  Adani Wilmar reports 13% volume growth in Q1 FY25
  06-Jul-24   14:44
  Tata Motors JLR wholesale rises 5% YoY in Q1
  06-Jul-24   13:01
  Marico's domestic biz sees modest volume growth in Q1
  06-Jul-24   12:25
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
Back Top